Phase IIa Trial of Anti-CD19 CAR T-Cells in Systemic Sclerosis Resistant to Immunosuppressive Therapy

Swipe the table sideways for more columns.

Trial	Conditions	Status	Phase	Updated	More info	NCT ID
Phase IIa Trial of Anti-CD19 CAR T-Cells in Systemic Sclerosis Resistant to Immunosuppressive Therapy	Skin and Connective Tissue Diseases, connective tissue disorder, skin disorder, systemic sclerosis	Active, not recruiting	Phase 2	2026-09-16		NCT07493395

1 results · Page 1 of 1

Swipe the table sideways for more columns.

Organizations	Linked trials
University Hospital, Montpellier	211

4 results · Page 1 of 1

Swipe the table sideways for more columns.

Research sites	City	Country	Linked trials
APHP Necker	Paris	France	1
CHRU Lille	Lille	France	32
CHU Rouen	Rouen	France	49
Montpellier University Hospital	Montpellier	France	3

Clinical trials